Novel 2-arylazoimidazole derivatives as inhibitors of Trypanosoma cruzi proliferation: Synthesis and evaluation of their biological activity
- 1 January 2017
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 125, 327-334
Abstract
No abstract availableKeywords
Funding Information
- Universidad de Buenos Aires (UBACyT 2013-2016 N° 20020120100015BA)
- CONICET
This publication has 33 references indexed in Scilit:
- Synthesis and structure–activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzainEuropean Journal of Medicinal Chemistry, 2015
- Designing and exploring active N′-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patientsEuropean Journal of Medicinal Chemistry, 2015
- Oral Transmission of Chagas DiseaseClinical Infectious Diseases, 2012
- Survey of Obstetrician-Gynecologists in the United States About Chagas DiseaseThe American Journal of Tropical Medicine and Hygiene, 2010
- Chagas diseaseThe Lancet, 2010
- Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, BrazilDiagnostic Microbiology and Infectious Disease, 2008
- Evaluation and Treatment of Chagas Disease in the United StatesJAMA, 2007
- Chagas disease in a recipient of cord blood transplantationBone Marrow Transplantation, 2007
- Specific chemotherapy of Chagas disease: controversies and advancesTrends in Parasitology, 2003
- Specific treatment of Chagas disease: current status and new developmentsCurrent Opinion in Infectious Diseases, 2001